期刊文献+

肝样腺癌4例 被引量:1

Four cases of hepatoid adenocarcinoma
下载PDF
导出
摘要 本文回顾性分析2008年1月~2013年12月南京大学医学院附属鼓楼医院诊治的4例肝样腺癌患者的临床资料,并综合文献报道探讨肝样腺癌的病理形态和临床特点。结果显示,4例患者中3例临床表现为消化道症状,仅因影像学肝占位收入院;3例血清甲胎蛋白含量异常并持续增高;2例伴有肝转移;3例伴淋巴结多发转移;4例患者存活均〈1年。肝样腺癌的临床症状无特殊性,容易忽视;血清甲胎蛋白多为阳性,是肝样腺癌确诊的一个重要参考指标;同时肝样腺癌易转移,治疗及预后较其他腺癌差,需引起医生的特别重视。 The pathological morphology and clinical characteristics of hepatoid adenocarcinoma were discussed in this text. Four cases clinical data of hepatoid adenocarcinoma from Drum Tower Hospital Affiliated to Medical School of Nanjing University were analyzed. Three in four patients manifest gastrointestinal symptoms including stomachache, in- appetence and malaise. Three of four hepatoid adenocarcinoma cases had a continuously increased level Of alpha fe- topmtein. Liver metastasis was observed in two cases and lymph node metastasis was found in three patients. All cases in this report were dead within one year after diagnosis. Hepatoid adenocarcinoma was difficult to diagnose due to its pathological morphology and clinical characteristics, which performs an increase of alpha fetopmtein, easy metastasis and bad prognosis. It should be paid more attention to diagnosis and treatment of hepatoid adenocarcinoma.
出处 《中国医药导报》 CAS 2014年第33期99-102,共4页 China Medical Herald
关键词 肝样腺癌 甲胎蛋白 病理 预后 Hepatoid adenocarcinoma Alpha fetopmtein Pathology Prognosis
  • 相关文献

参考文献17

  • 1Bourreille J,Metayer P,Sauger F,et al.Existence of alpha feto protein during gastric-origin secondary cancer of the liver[J].La Presse Medicale,1970,78(28):1277-1278.
  • 2Ishikura H,Kirimoto K,Shamoto M,et al.Hepatoid adenocarcinomas of the stomach.An analysis of seven cases[J].Cancer,1986,58 (1):119-126.
  • 3Min-Feng Ye,Feng Tao,Fang Liu,Ai-Jing Sun.Hepatoid adenocarcinoma of the stomach: A report of three cases[J].World Journal of Gastroenterology,2013,19(27):4437-4442. 被引量:9
  • 4Baek SK,Han SW,Oh DY,et al.Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach,a rare but unique subtype of gastric cancer[J].BMC Gastroenterology,2011,11:56.
  • 5Gao YB,Zhang DF,Jin XL,et al.Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma[J].Journal of digestive diseases,2007,8(1):23-28.
  • 6王孝廉.胃的肝样腺癌[J].山西医药杂志,1987,16(6):330-331,393.
  • 7Jiann-Sheng Su,Yu-Tso Chen,Ren-Ching Wang,Chun-Ying Wu,Shou-Wu Lee,Teng-Yu Lee.Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma:A literature review[J].World Journal of Gastroenterology,2013,19(3):321-327. 被引量:80
  • 8Caruso RA,Basile F,Fedele F,et al.Gastric hepatoid adenocarcinoma with autophagy-related necrosis-like tumor cell death:report of a case[J].Ultrastructural Pathology,2006,30 (4):301-307.
  • 9Cappetta A,Bergamo F,Mescoli C,et al.Hepatoid adenocarcinoma of the colon:what should we target?[J].Pathology Oncology Research,2012,18 (1):93-96.
  • 10Wu QY,Wan XY,Xie X,et al.Endometrial hepatoid adenocarcinoma:a rare cause of elevated serum alpha-fetoprotein[J].Journal of Obstetrics and Gynaecology research,2014,40(3):873-877.

二级参考文献36

  • 1Research Center of Clinical Medicine,Affiliated Hospital of Nantong University,Nantong 226001,China (Yao M,Yao DF,Qiu LW,Wu W,Sai WL,Yang JL and Zhang HJ),Department of Oncology,Yancheng First People’s Hospital,Yancheng 224001,China (Bian YZ),Department of Oncology,Second Affiliated Hospital,Nanjing Medical University,Nanjing 210011,China (Zhang CG).Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2011,10(3):289-294. 被引量:51
  • 2Jiann-Sheng Su,Yu-Tso Chen,Ren-Ching Wang,Chun-Ying Wu,Shou-Wu Lee,Teng-Yu Lee.Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma:A literature review[J].World Journal of Gastroenterology,2013,19(3):321-327. 被引量:80
  • 3王孝廉.胃的肝样腺癌[J].中华肿瘤杂志,1988,10(6):455-456.
  • 4Ishikura H,Fukasawa Y,Ogasawara K,et al.An AFPproducing gastric carcinoma with features of hepatic differentiation,a case report.Cancer,1985,56:840-848.
  • 5Ghang YC,Nagasue H,Kohon H,et al.Clinicopathologic featues and long-term results of alpha-fetovroteiu-producing gastric cancer.Am J Gastroenteral,1990,85:1480-1485.
  • 6林琦远,杨家卿.肝恶性肿瘤的肝移植.严律南,主编.现代肝脏移植学.北京:人民第一出版社,2004.483-495.
  • 7Rosenau J,Banr MJ,Von Wasielewski R,et al.Ki67,Ecadherin and P53 as prognostic indicadors of long-term outcome after liver transplantation for metastatic nuroendocrine tumors.Transplantation,2002,73:386.
  • 8H. Gakiopoulou,N. Givalos,G. Liapis,G. Agrogiannis,E. Patsouris,I. Delladetsima.Hepatoid Adenocarcinoma of the Gallbladder[J].Digestive Diseases and Sciences.2007(12)
  • 9A. Lopez-Beltran,R. J. Luque,A. Quintero,M. J. Requena,R. Montironi.Hepatoid adenocarcinoma of the urinary bladder[J].Virchows Archiv.2003(4)
  • 10G. Bombski,A. Gasiorowska,D. Orszulak-Michalak,B. Neneman,J. Kotynia,J. Strzelczyk,A. Janiak,E. Malecka-Panas.Elevated plasma gastrin, CEA, and CA 19-9 levels decrease after colorectal cancer resection[J].International Journal of Colorectal Disease.2003(2)

共引文献93

同被引文献30

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部